Cargando…
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
OBJECTIVES: To investigate safety and efficacy of MMF in patients with severe or MTX-refractory juvenile localized scleroderma. METHODS: Consecutive juvenile localized scleroderma patients undergoing systemic treatment were included in a retrospective longitudinal study. Patients treated with MMF be...
Autores principales: | Martini, Giorgia, Saggioro, Laura, Culpo, Roberta, Vittadello, Fabio, Meneghel, Alessandra, Zulian, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937018/ https://www.ncbi.nlm.nih.gov/pubmed/32978631 http://dx.doi.org/10.1093/rheumatology/keaa392 |
Ejemplares similares
-
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini, G, et al.
Publicado: (2008) -
Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011) -
Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study
por: Martini, Giorgia, et al.
Publicado: (2023) -
Systemic sclerosis sine scleroderma in children
por: Zulian, Francesco, et al.
Publicado: (2021) -
PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients
por: Culpo, R, et al.
Publicado: (2013)